- ETF Trends•4 days ago
The BioShares Biotechnology Products Fund (NasdaqGM: BBP) has capitalized on a string of acquisitions and outperformed other biotechnology- and pharmaceuticals-related exchange traded funds. BBP, which ...
- Capital Cube•4 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Progenics Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Progenics Pharmaceuticals, Inc. : July 21, 2016 appeared first on CapitalCube.
Progenics Pharmaceuticals, Inc.NasdaqGS
After hours: 6.060.14 (2.36%) as of 5:39 PM EDT
|Bid||5.93 x 11800|
|Ask||6.06 x 1000|
|52wk Range||3.61 - 11.15|
|Day's Range||5.89 - 6.18|
|Avg Vol (3m)||1,334,398|
As of 4:00 PM EDT. Market closed.